Investigating the Anti-inflammatory Mechanism of <i>Alpinia purpurata</i> (Vieill.) K. Schum. Rhizome Extract: Metabolite Profiling, Network Pharmacology, in vitro Safety, and in vivo Validation

AuthorKiki Mulkiya Yuliawatien
AuthorFahriza Salsabilla Yuniaren
AuthorEllin Febrinaen
AuthorGofarana Wilaren
AuthorRaden Maya Febriyantien
AuthorDeshanda Kurniawan Prayogaen
AuthorFaisal Kuswandanien
AuthorSri Adi Sumiwien
AuthorSupat Jiranusornkulen
AuthorJutti Levitaen
OrcidEllin Febrina [0000-0003-3004-5069]en
OrcidGofarana Wilar [0000-0002-0904-3117]en
OrcidRaden Maya Febriyanti [0000-0002-3437-3011]en
OrcidFaisal Kuswandani [0000-0001-6301-6243]en
OrcidSri Adi Sumiwi [0000-0002-7155-8592]en
OrcidJutti Levita [0000-0002-4578-4174]en
Issued Date2026-12-31en
AbstractBackground: Alpinia purpurata has shown promising effects in alleviating inflammatory conditions; however, its underlying mechanisms require further investigation. Objectives: This study aimed to elucidate the molecular mechanisms underlying the anti-inflammatory activity of A. purpurata rhizome extract (EEAP) and its active metabolites through the TLR4/MyD88 pathway. Methods: The EEAP was analyzed for proximate composition, vitamin C content, total phenolic content (TPC), total flavonoid content (TFC), total monomeric anthocyanin content (TMAC), and metabolite profile, followed by a network pharmacology analysis. Cytotoxicity was evaluated in HEK-293 cells. An in vivo study of carrageenan-induced paw edema in rats was conducted to validate the findings. Results: EEAP contained 42.12% ash, 34.66% moisture, 6.03% protein, 16.60% fat, and 0.59% carbohydrate. The vitamin C content was 941.55 mg/100 g extract, the TPC was 452.9 mg GAE/100 g extract, the TFC was 416.1 mg QUE/100 g extract, and the TMAC was 2770 mg/100 g extract. Functional enrichment analysis identified the TLR4/MyD88 signaling pathway as contributing to IL-23 production. Eight metabolites with anti-inflammatory properties were verified based on their Pa values: glycidyl oleate, 1-stearoylglycerol, alpha-linolenic acid, methyl palmitate, shogaol, 4-methoxybenzaldehyde, ginkgoneolic acid, and curcumene. EEAP was not toxic to HEK-293 cells (IC50= 741.1 μg/mL) compared with quercetin (IC50= 96.73 μg/mL) and cisplatin (IC50= 7.44 μg/mL). EEAP reduced edema volume but did not alter TLR4 or MyD88 expression under the present experimental conditions. Conclusions: EEAP is not toxic to normal cells and exerts an anti-inflammatory effect by reducing edema volume in carrageenan-induced rats; however, it does not alter the TLR4/MyD88 pathway.en
DOIhttps://doi.org/10.5812/ijpr-169725en
URIhttps://brieflands.com/journals/ijpr/articles/169725en
Keyword<i>Alpinia</i> Speciesen
KeywordDrug Discoveryen
KeywordInflammationen
KeywordQuercetinen
KeywordShogaolen
KeywordZingiberaceaeen
PublisherBrieflandsen
TitleInvestigating the Anti-inflammatory Mechanism of <i>Alpinia purpurata</i> (Vieill.) K. Schum. Rhizome Extract: Metabolite Profiling, Network Pharmacology, in vitro Safety, and in vivo Validationen
TypeResearch Articleen

Files